RG
ANAB icon

Redmile Group’s AnaptysBio ANAB Stock Holding History

Redmile Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-612,558
Closed -$21.4M – 65
2019
Q3 		$21.4M Buy
612,558
+2,900
+0.5% +$138K 0.72% 44
2019
Q2 		$34.4M Buy
609,658
+112,740
+23% +$8.12M 0.97% 30
2019
Q1 		$36.3M Buy
496,918
+132,868
+36% +$9.17M 1.06% 31
2018
Q4 		$23.2M Sell
364,050
-266,200
-42% -$19.8M 0.93% 34
2018
Q3 		$62.9M Buy
630,250
+111,000
+21% +$9.21M 1.93% 18
2018
Q2 		$36.9M Sell
519,250
-3,900
-0.7% -$327K 1.25% 28
2018
Q1 		$54.4M Buy
523,150
+293,300
+128% +$33.1M 2.1% 16
2017
Q4 		$23.1M Buy
+229,850
New +$16.9M 1.01% 36

Other funds holding ANAB

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group's ANAB Position: Q4 2019 in Review

Redmile Group sold out of AnaptysBio (ANAB) in Q4 2019, closing a stake of 612,558 shares — an estimated $21.4M sold.

Redmile Group first reported a position in ANAB in Q4 2017 and held it in 8 quarters. The position peaked at $62.9M in Q3 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

  • Redmile Group reported no remaining AnaptysBio position as of Q4 2019 after selling out during the quarter.
  • Redmile Group sold 612,558 AnaptysBio shares in Q4 2019, an estimated $21.4M.
  • Redmile Group first reported a position in AnaptysBio in Q4 2017 and held it in 8 quarters.
  • Redmile Group's AnaptysBio position peaked at $62.9M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Redmile Group's 13F filing for Q4 2019, filed 14 Feb 2020.